These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15106086)

  • 21. Progress toward the 2012 measles elimination goal--Western Pacific Region, 1990-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):669-73. PubMed ID: 19553903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination levels associated with lack of measles transmission among preschool-aged populations in the United States, 1989-1991.
    Hutchins SS; Baughman AL; Orr M; Haley C; Hadler S
    J Infect Dis; 2004 May; 189 Suppl 1():S108-15. PubMed ID: 15106099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
    Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
    Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in global measles control and mortality reduction, 2000-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(47):1237-41. PubMed ID: 18046301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interruption of measles transmission in Brazil, 2000-2001.
    Prevots DR; Parise MS; Segatto TC; Siqueira MM; dos Santos ED; Ganter B; Perreira MC; Domingues CA; Lanzieri T; Da Silva JB
    J Infect Dis; 2003 May; 187 Suppl 1():S111-20. PubMed ID: 12721901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the status of measles elimination from reported outbreaks: United States, 1997-1999.
    Gay NJ; De Serres G; Farrington CP; Redd SB; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S36-42. PubMed ID: 15106087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring measles eradication in the region of the Americas: critical activities and tools.
    Izurieta H; Venczel L; Dietz V; Tambini G; Barrezueta O; Carrasco P; Quiroga R; André J; Castillo-Solórzano C; Brana M; Laender F; de Quadros CA
    J Infect Dis; 2003 May; 187 Suppl 1():S133-9. PubMed ID: 12721904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness.
    Velicko I; Müller LL; Pebody R; Gergonne B; Aidyralieva C; Kostiuchenko N; Spika JS
    Vaccine; 2008 Dec; 26(52):6980-5. PubMed ID: 18805455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of a measles elimination strategy on measles incidence in Malaysia.
    Saraswathy TS; Zahrin HN; Norhashmimi H; Az-Ulhusna A; Zainah S; Rohani J
    Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):742-7. PubMed ID: 19842408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
    Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of measles elimination in development of a national immunization program.
    Orenstein WA
    Pediatr Infect Dis J; 2006 Dec; 25(12):1093-101. PubMed ID: 17133153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scheduling of measles vaccination in low-income countries: projections of a dynamic model.
    Bauch CT; Szusz E; Garrison LP
    Vaccine; 2009 Jun; 27(31):4090-8. PubMed ID: 19410622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(7):175-8. PubMed ID: 15729220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative use of surveillance data to harness political will to accelerate measles elimination: experience from Guangxi, China.
    Zhuo J; Hoekstra EJ; Zhong G; Liu W; Zheng Z; Zhang J
    J Infect Dis; 2011 Jul; 204 Suppl 1():S463-70. PubMed ID: 21666200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global measles mortality, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(47):1321-6. PubMed ID: 19959985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in measles control--Kenya 2002-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):969-72. PubMed ID: 17882128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress toward measles elimination--region of the Americas, 2002-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(14):304-6. PubMed ID: 15085074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia.
    Wood JG; Gidding HF; Heywood A; Macartney K; McIntyre PB; Macintyre CR
    Vaccine; 2009 Jan; 27(2):313-8. PubMed ID: 18977272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in global measles control and mortality reduction, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(48):1303-6. PubMed ID: 19052529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of measles elimination activities on immunization services and health systems: findings from six countries.
    Hanvoravongchai P; Mounier-Jack S; Oliveira Cruz V; Balabanova D; Biellik R; Kitaw Y; Koehlmoos T; Loureiro S; Molla M; Nguyen H; Ongolo-Zogo P; Sadykova U; Sarma H; Teixeira M; Uddin J; Dabbagh A; Griffiths UK
    J Infect Dis; 2011 Jul; 204 Suppl 1():S82-9. PubMed ID: 21666218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.